Beta carotene studies "put to rest" cancer, heart disease prevention hopes -- NEJM editorial.
This article was originally published in The Tan Sheet
BETA CAROTENE STUDIES "PUT TO REST" HOPES FOR LOWERING CANCER, HEART DISEASE RISK, according to an editorial in the May 2 New England Journal of Medicine. Two studies, published in the same issue of the NEJM, "should put to rest any remaining hopes that, for adults, beta carotene supplements may be an effective means of lowering the risk of cancer and cardiovascular disease," Robert Greenberg, MD, and Michael Sporn, MD, Dartmouth Medical School, assert.
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC